Tauriga Sciences, Inc. Confirms that 10,000 Units of “HerMan” Product Inventory Have Been Delivered by Manufacturer

NEW YORK, NY, Dec 28, 2017 (GLOBE NEWSWIRE via COMTEX) —

Tauriga Sciences, Inc. (OTC PINK: TAUG) (“Tauriga” or the “Company”), engaged in building business through the development, distribution, and licensing of proprietary products as well as the evaluation of potential acquisition opportunities/equity investments, today announced that the entirety of its retail grade “HerMan” product inventory (“marketable inventory”) has now been delivered by the New Jersey based Manufacturer (10,000 Units). These 10,000 units of product inventory have been received at the fulfillment center of Tauriga’s licensor, Cleveland, Ohio based cosmetics firm Ice + Jam LLC (“Ice + Jam”). The Company previously disclosed, on December 7, 2017, that multiple customer orders had been placed for the product; there have also been a number of orders received via the internet (http://www.iceandjam.com/shop/herman-cupuacu-butter-balm).

From a composition analysis, HerMan is primarily composed of the compound Theobroma Grandiflorium (“Cupuacu Butter” or “Superfruit”) to leverage the potential benefits that have been well documented historically (see paragraph directly below).

Cupuacu Butter is derived from the fruit of the Cupuacu Tree; a tropical rainforest tree related to Cacao (the base of chocolate production). Common throughout the Amazon basin (South America), it is widely cultivated in the jungles of Colombia, Bolivia and Peru and in the north of Brazil, with the largest production in Par�, followed by Amazonas, Rond�nia and Acre. Cupuacu Butter is a good plant-based alternative to lanolin, offering the capacity to attract 240% more water allowing it to function much more effectively as a skin hydrator and moisturizer. In addition, though it’s not recognized as an SPF (Sun Protection Factor), Cupuacu Butter is well known for its ability to absorb damaging UVA / UVB rays (“Ultra Violet Rays”) for natural sun protection.

No Comments

Sorry, the comment form is closed at this time.